Foamlab
Develops and manufactures bacterial cellulose foam materials designed to replace fossil-based plastics across industrial and consumer foam applications.
Overview
Foamlab develops bacterial cellulose foam materials intended as biobased replacements for fossil-derived plastics. The company targets industrial and consumer users of foam products and positions its materials as an alternative to petrochemical foams across multiple use cases. Based in Delft, Foamlab centers its differentiation on using bacterial cellulose as the core material, offering a biologically produced foam rather than synthetic polymers. The company completed a €3 million growth capital round in April 2026, its only disclosed financing to date, to advance development and commercial deployment.
Funding History
Delft’s Foamlab raises €3 million to replace fossil-based plastics with its bacterial cellulose foams
Frequently Asked Questions
- How much funding does AI Funding track for Foamlab?
- AI Funding tracks €3M for Foamlab across 1 funding round in this database.
- Who are Foamlab's investors?
- Foamlab's investors include ICOS Capital, Value Factory Ventures, DOEN Ventures, Capricorn Industrial Biotech Fund, TTT Green Tech.
- What does Foamlab do?
- Foamlab develops bacterial cellulose foam materials intended as biobased replacements for fossil-derived plastics. The company targets industrial and consumer users of foam products and positions its materials as an alternative to petrochemical foams across multiple use cases. Based in Delft, Foamlab centers its differentiation on using bacterial cellulose as the core material, offering a biologically produced foam rather than synthetic polymers. The company completed a €3 million growth capital round in April 2026, its only disclosed financing to date, to advance development and commercial deployment.
- Where is Foamlab headquartered?
- Foamlab is headquartered in Delft, Netherlands.
Investors
Related Insights
Compare the leading AI-focused VC firms: Andreessen Horowitz, Sequoia Capital, Thrive Capital, and 7 more. Analysis of 150+ AI deals, investment strategies, sector focus, and portfolio performance.
Track 395+ AI funding rounds—investors, valuations, and deal sizes from pre-seed to IPO. Updated daily so you never miss a round.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.